KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-015-1936-z
Published Online: 2015-12-01
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Gravina, Giovanni Luca
Mancini, Andrea
Sanita, Patrizia
Vitale, Flora
Marampon, Francesco
Ventura, Luca
Landesman, Yosef
McCauley, Dilara
Kauffman, Michael
Shacham, Sharon
Festuccia, Claudio
License valid from 2015-12-01